I just heard a programme on the BBC World Service in the One Planet series called “Nuts.” It looked at the problems encountered in developing the Brazil nut as a source of income for poor Amazonian farmers. Unfortunately, it appears that some very tight – some would say unreasonably tight – EU regulations about levels of aflavotoxins are preventing exports. There’s part two next week. The website for the One Planet series is here, but this particular programme does not seem to be online yet. I’ll keep looking out for it. Coincidentally, WWF also has a long piece on the Brazil nut out today, which you can find here. International Trade Forum had a piece on Brazil nuts here in 2004.
Health and agriculture
To follow the last post, here’s a photo-essay from the BBC on another useful insect, the “desert shrimp,” better known as the locust. Useful? Well, that may be overstating the case, but they are widely eaten in the Sahara, deep fried in vegetable oil. I have tried them. Not as bad as one might think.
Anyway, what I really wanted to alert you all to is that the latest Spore and New Agriculturalist are out. There are lots of interesting pieces, both brief and longer, but is it a coincidence that both issues focus on aspects of agriculture and health? Spore has a feature on “functional foods” here, things that provide disease prevention as well as nutrition. New Agriculturalist has number of articles on various different aspects of the topic here, plus other sources of information.
Bats to the rescue
The other Economist article I wanted to mention deals with bats and how useful they are to agriculture, as pollinators (e.g. Agave) and – the main point of the piece – as predators of agricultural pests. Work in Texas is actually trying to quantify the benefit that bats bring to famers of cotton and other crops as they munch their way through moth populations in their millions. Always good to be able to put $ values on biodiversity.
Opium poppies
There are a couple of interesting articles in this week’s print issue of The Economist, but they are both premium content on the web, so I’ve dug a bit deeper for you and will post on them separately. One article contrasts the global shortage of opiates for medical use with the efforts being made to stop Afghani farmers growing the opium poppy for the heroin trade. A crazy situation. One possible solution is licensing farmers to grow the crop under strict controls, but that is not without difficulties, especially in a place like Afghanistan. However, there is a possible scientific solution. It turns out that Tasmania, of all places, is an important opium poppy producer, and researchers at “Tasmanian Alkaloids recognised that there was a possibility of breeding a poppy variety in which the biosynthetic pathway stopped at thebaine instead of going on to produce morphine.” That would make it ok for therapeutic opiate production but useless for the illicit drug trade. You can read all about it here. There’s a paper on poppy transformation here and one on poppy genetic diversity here.
Farming Hoodia
Another example of a wild species being farmed: this article in the San Francisco Chronicle tells the story of Hoodia gordonii cultivation in southern Africa. The species is the source of a hunger suppressant which Unilever has been licensed to commercialize, with a royalty payment going to San tribesmen. Another Hoodia species may have potential as a salad vegetable. Prices are such that there is a thriving smuggling trade in wild-harvested product. Some Namibian farmers are trying to cultivate the plant – organically – but it is not easy.